David Brennan appointed chairman of PhRMA
This article was originally published in Scrip
Executive Summary
AstraZenenca's CEO David Brennan has been elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA).He will succeed the incumbent Richard Clark, CEO of Merck & Co. Pfizer's CEO Jeffery Kindlerhas been appointed chairman-elect.